CARE Ratings Limited Schedules Analyst/Institutional Investor Meet for March 25, 2026

1 min read     Updated on 20 Mar 2026, 03:51 PM
scanx
Reviewed by
Radhika SScanX News Team
Overview

CARE Ratings Limited has scheduled an analyst and institutional investor meeting with OysterRock Capital for March 25, 2026, at 3:30 PM in an in-person format. The announcement, made in compliance with SEBI Regulation 30, confirms that discussions will be based on publicly available information, with the Q3FY26 investor presentation already accessible on the company's website.

35547688

*this image is generated using AI for illustrative purposes only.

CARE Ratings Limited has formally announced an analyst and institutional investor meeting scheduled for March 25, 2026, in accordance with Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company communicated this development to both BSE Limited and The National Stock Exchange of India Ltd. on March 20, 2026.

Meeting Details

The scheduled investor engagement presents the following specifics:

Parameter: Details
Fund/Research House: OysterRock Capital
Meeting Date: March 25, 2026
Time: 03:30 PM
Format: In Person
Event Type: Analyst/Institutional Investor Meet

Regulatory Compliance and Documentation

The company has emphasized that all discussions during the meeting will be based exclusively on publicly available information, ensuring transparency and regulatory compliance. CARE Ratings has proactively made the investor presentation available on its official website, specifically the Q3FY26 presentation document.

The company has also noted that the meeting schedule may undergo changes due to exigencies on the part of either the investor or the company, providing flexibility for both parties involved.

Corporate Communication

The formal intimation was signed by Manoj Kumar CV, Company Secretary & Compliance Officer of CARE Ratings Limited, and was digitally executed on March 20, 2026. This structured approach to investor relations demonstrates the company's commitment to maintaining transparent communication with its stakeholder community while adhering to prescribed regulatory frameworks.

Historical Stock Returns for CARE Ratings

1 Day5 Days1 Month6 Months1 Year5 Years
+2.98%-7.05%-8.24%-6.31%+26.62%+231.34%

CARE Ratings Approves ₹22.5 Crore Joint Venture 'Operus Limited' With Vestian

1 min read     Updated on 17 Mar 2026, 08:33 PM
scanx
Reviewed by
Radhika SScanX News Team
Overview

CARE Ratings Limited has received committee approval to form a 50:50 joint venture called 'Operus Limited' with Vestian Global Work Place Services, investing ₹22.5 crores in Global Capability Centre enablement services. The JV will provide end-to-end GCC solutions for global enterprises in India, with incorporation expected by June 30, 2026, subject to SEBI NOC approval.

35305034

*this image is generated using AI for illustrative purposes only.

CARE Ratings Limited has received approval from its Strategy and Investment Committee for the incorporation of a joint venture company named 'Operus Limited' with Vestian Global Work Place Services Private Limited, as announced in a regulatory filing on March 17, 2026.

Joint Venture Structure and Investment

The Strategy and Investment Committee, duly authorized by the Board, approved the formation of this 50:50 joint venture during its meeting held on March 17, 2026. The partnership details are structured as follows:

Parameter: Details
JV Company Name: Operus Limited
Shareholding Structure: 50% CARE Ratings, 50% Vestian Global
Initial Investment: ₹22.5 crores
Share Price: ₹10 per share (Face Value)
Target Completion: June 30, 2026

Business Focus and Operations

Operus Limited will operate in the Global Capability Centre (GCC) enablement services industry. The proposed company will enable global enterprises to design, establish, and operate Global Capability Centres in India, delivering comprehensive solutions across multiple domains.

The joint venture will provide end-to-end services including strategy development, operating model design, talent acquisition, workspace setup, and regulatory compliance. Through managed services and relevant business models, Operus will deliver enterprise-grade, scalable GCCs aligned with clients' long-term global objectives while maintaining governance excellence.

Regulatory Requirements and Timeline

The incorporation requires a No-Objection Certificate (NOC) from the Securities and Exchange Board of India (SEBI). CARE Ratings has indicated that the incorporation process is expected to be completed tentatively by June 30, 2026.

Strategic Significance

This joint venture represents CARE Ratings' strategic expansion beyond its traditional credit rating services into the growing GCC enablement sector. The partnership with Vestian Global Work Place Services combines expertise from both organizations to capitalize on the increasing demand for Global Capability Centre services in India.

The committee meeting commenced at 1:00 p.m. and concluded at 3:40 p.m., with the announcement made in compliance with Regulation 30 of the SEBI Listing Obligations and Disclosure Requirements Regulations, 2015.

Historical Stock Returns for CARE Ratings

1 Day5 Days1 Month6 Months1 Year5 Years
+2.98%-7.05%-8.24%-6.31%+26.62%+231.34%

More News on CARE Ratings

1 Year Returns:+26.62%